The Therapeutic Goods Administration (TGA) is part of the Australian Federal Government’s Department of Health and regulates the supply, import, export, manufacturing, and advertising of therapeutic goods, including medicines in Australia.
2023 Medical Device Manufacturing Trends
Welcoming the 2023 Spring Cohort of GMP Students at UTS
SeerPharma is thrilled to welcome the 2023 Spring cohort of students studying Good Manufacturing Practice (GMP) at the University of Technology Sydney (UTS). This unique program is designed and delivered by SeerPharma in partnership with UTS. We’re thrilled to see close to 100 students now undergoing Postgraduate training in GMP with us at UTS....
If we could predict the future of the pharma manufacturing industry, we wouldn’t have been rattled by supply disruptions throughout the pandemic. And we would’ve been able to anticipate which products would unexpectedly experience weak demand. At the very least, we could’ve predicted which winning therapies to invest in! So why do we waste time...
SeerPharma has been engaged by multiple companies to conduct GMP audits in the Asia-Pacific region on behalf of Qualified Persons (QP) in Europe.
The Singaporean division of a global diagnostics equipment manufacturer engaged SeerPharma to deliver training on Computer Software Assurance/Validation and 21 CFR Part 11. Multiple workshops were delivered to over 50 staff, to help them appreciate the regulatory expectations of the US FDA , for the work performed on-site.
A leading sterile pharmaceutical manufacturer in India engaged SeerPharma to assist in responding to a recent TGA GMP audit. As part of its response to the TGA, the company requested SeerPharma to visit their site in Madhya Pradesh. SeerPharma was tasked to assess the clients’ sterile facilities, documentation, quality management system, risk...
Publicly debuted Large Language Models (LLMs), such as ChatGPT by OpenAI (Microsoft), have initiated serious rethinking of business processes across all sectors of the economy. Consultancy firms are not immune from the potential disruption caused by these novel artificial intelligence (AI) tools. Global consulting firm PwC has recently instructed...
SeerPharma to Exhibit at ARCS 2023 June 6-8th
The Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry (ARCS) is an eminent organisation that focuses on the professional development of individuals involved in the therapeutic goods industry. To further its mission, ARCS hold an annual conference, which will be run from the 6th-8th of June at the...
SeerPharma has over 30 years of experience, supporting diagnostic manufacturers and laboratories on matters related to Quality and GxP compliance. In that time , we’ve seen the emergence and importance of Point of Care Diagnostics (POCD). Following this trend, we’re delighted to be sponsoring an upcoming Biosymposium by the Biomelbourne Network...